NL-OMON46147
Completed
Not Applicable
A Multicentre, Prospective, Longitudinal, Observational Natural History Study to Evaluate Disease Progression in Subjects with Usher Syndrome type 1B (USH1B) - Natural history of Usher syndrome type 1B
Oogziekenhuis Rotterdam0 sites10 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Usher syndrome type 1B
- Sponsor
- Oogziekenhuis Rotterdam
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Informed consent
- •Diagnosed with USH1
- •Molecular diagnosis of USH1B due to MYO7A mutations (homozygotes or compound heterozygotes)
- •Age \>\= 8 years
- •Visual acuity \>\= 20/640 in at least one eye
Exclusion Criteria
- •Unable to communicate with suitable verbal/auditory and/or tactile sign language
- •Participation in clinical study with investigational drug in past 6 months
- •Pre\-existing ocular conditions that would interfere with the interpretation of study
- •endpoints (e.g. glaucoma, corneal or significant lenticular opacities, cystoid macular oedema, macular hole) in both eyes
- •Complicating systemic diseases in which the disease itself, or the treatment for the disease,
- •can alter ocular function
- •Prior ocular surgery within 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A prospective long-term multi-center observational study for the timely update of optimal social medical system and individualized treatment strategy in patients with acute coronary syndrome: REVEIL-ACS registryJPRN-UMIN000053536Osaka University Graduate School of Medicine5,000
Active, not recruiting
Not Applicable
A post-market prospective clinical study of Nagor PERLE™ mammary implantsBreast surgery: augmentation and reconstruction including revision for womenSurgeryISRCTN96851026agor Ltd700
Unknown
Not Applicable
Observational Study in Patients With Autosomal Dominant Polycystic Kidney DiseaseAutosomal dominant polycystic kidney disease (ADPKD)JPRN-jRCT1080221699Otsuka Pharmaceutical Dvelopment & Commercialization, Inc.3,000
Completed
Phase 4
A Multi-center, Longitudinal, Observational Study of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) to Establish the Rate, Characteristics, and Determinants of Disease ProgressioADPKDautosomal polycystic kidney disease10029149NL-OMON36219Otsuka America Pharmaceutical100
Recruiting
Not Applicable
The SMuRFless Coronary Artery Disease (CAD) Registry: An observational study of the quality of care and risk factors in patients with CAD but without Standard Modifiable cardiovascular Risk Factors (SMuRFs)Cardiovascular diseaseCardiovascular - Coronary heart diseaseACTRN12622000452796The University of Sydney1,000